+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Parenteral Analgesics Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 150 Pages
  • October 2026
  • Region: Global
  • Grand View Research
  • ID: 6292338
The global parenteral analgesics market size was valued at USD 5.0 billion in 2025 and is projected to grow from USD 5.2 billion in 2026 to USD 7.5 billion by 2033, at a CAGR of 5.4% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 41.2% in 2025. The market growth is driven by the rising demand for pain management in surgical procedures, post-operative recovery, and emergency departments.

The parenteral analgesics industry comprises injectable medicines used to manage pain when rapid relief is required or oral administration is unsuitable. These medicines are administered mainly through intravenous, intramuscular, and subcutaneous routes in hospitals and other clinical care settings. The market includes opioid analgesics, non-opioid analgesics, and other injectable medicines used for pain control. Product selection depends on the cause and severity of pain, the patient’s clinical condition, the required onset of action, and the duration of treatment. Parenteral analgesics are used in emergency care, surgery, post-operative recovery, and the management of pain associated with certain acute and chronic conditions. Hospitals remain an important point of use because injectable pain medicines require clinical assessment, dose selection, administration, and monitoring. Demand is also linked to surgical activity, emergency admissions, and access to healthcare services that pro

vide supervised pain management, including recovery and critical care units.

Acute pain management is an important area of use, particularly after surgery, trauma, and during emergency treatment. Injectable medicines are also used when patients cannot take oral medicines or when a controlled dose is required under clinical supervision. Chronic pain treatment is more varied, and parenteral analgesics are generally used for selected clinical needs rather than as a routine option for every patient with persistent pain. The wider burden of pain supports the need for effective treatment, although not all people experiencing pain require injectable medicines. Treatment decisions depend on the underlying condition, patient response, safety considerations, and the availability of alternative pain management options. Multimodal pain management, which combines medicines with different mechanisms of action, also supports the use of selected injectable analgesics in surgical and hospital care.

Market demand is shaped by clinical guidelines, product availability, hospital purchasing practices, medicine prices, and national rules for controlled substances. Opioid analgesics remain relevant for severe pain, but their use requires attention to dosage, adverse effects, dependence risks, and prescribing controls. Non-opioid injectable medicines provide options for selected pain management needs and can be used as part of multimodal treatment, depending on the patient and procedure. Manufacturers compete through product range, supply reliability, regulatory compliance, and relationships with hospitals and distributors. Shortages of active ingredients or finished injectable products can affect access, while sterile manufacturing requirements and quality controls influence production and supply. The market also differs across regions because healthcare infrastructure, surgical services, reimbursement policies, and access to pain specialists vary. Demand will depend on clinical need,

safe prescribing, product supply, and the availability of injectable analgesics within hospital care.

Global Parenteral Analgesics Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global parenteral analgesics market report based on drug class, route of administration, application, end user, and region:

Drug Class Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Opioid Analgesics
  • Non-Opioid Analgesics
  • Others

Route of Administration Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Intravenous (IV)
  • Intramuscular (IM)
  • Subcutaneous (SC)
  • Others

Application Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Acute Pain
  • Chronic Pain

End User Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug Class
1.2.2. Route of Administration
1.2.3. Application
1.2.4. End User
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. The internal database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Parenteral Analgesics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pricing Analysis
Chapter 4. Parenteral Analgesics Market: Drug Class Business Analysis
4.1. Drug Class Market Share, 2025 & 2033
4.2. Drug Class Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, Drug Class, 2021 to 2033 (USD Million/Billion)
4.4. Opioid Analgesics
4.4.1. Opioid Analgesics Market, 2021 - 2033 (USD Million/Billion)
4.5. Non-Opioid Analgesics
4.5.1. Non-Opioid Analgesics Market, 2021 - 2033 (USD Million/Billion)
4.6. Others
4.6.1. Others Market, 2021 - 2033 (USD Million/Billion)
Chapter 5. Parenteral Analgesics Market: Route of Administration Business Analysis
5.1. Route of Administration Market Share, 2025 & 2033
5.2. Route of Administration Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, Route of Administration, 2021 to 2033 (USD Million/Billion)
5.4. Intravenous (IV)
5.4.1. Intravenous (IV) Market, 2021 - 2033 (USD Million/Billion)
5.5. Intramuscular (IM)
5.5.1. Intramuscular (IM) Market, 2021 - 2033 (USD Million/Billion)
5.6. Subcutaneous (SC)
5.6.1. Subcutaneous (SC) Market, 2021 - 2033 (USD Million/Billion)
5.7. Others
5.7.1. Others Market, 2021 - 2033 (USD Million/Billion)
Chapter 6. Parenteral Analgesics Market: Application Business Analysis
6.1. Application Market Share, 2025 & 2033
6.2. Application Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, Application, 2021 to 2033 (USD Million/Billion)
6.4. Acute Pain
6.4.1. Acute Pain Market, 2021 - 2033 (USD Million/Billion)
6.5. Chronic Pain
6.5.1. Chronic Pain Market, 2021 - 2033 (USD Million/Billion)
Chapter 7. Parenteral Analgesics Market: End User Business Analysis
7.1. End User Market Share, 2025 & 2033
7.2. End User Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, End User, 2021 to 2033 (USD Million/Billion)
7.4. Hospitals
7.4.1. Hospitals Market, 2021 - 2033 (USD Million/Billion)
7.5. Ambulatory Surgical Centers
7.5.1. Ambulatory Surgical Centers Market, 2021 - 2033 (USD Million/Billion)
7.6. Specialty Clinics
7.6.1. Specialty Clinics Market, 2021 - 2033 (USD Million/Billion)
7.7. Others
7.7.1. Others Market, 2021 - 2033 (USD Million/Billion)
Chapter 8. Parenteral Analgesics Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2025 & 2033
8.2. Regional Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
8.4. North America
8.4.1. North America Parenteral Analgesics Market Estimates and Forecasts, Country, 2021-2033 (USD Million/Billion)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. Regulatory Framework
8.4.2.3. Reimbursement Framework
8.4.2.4. U.S. Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Regulatory Framework
8.4.3.3. Reimbursement Framework
8.4.3.4. Canada Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Regulatory Framework
8.4.4.3. Reimbursement Framework
8.4.4.4. Mexico Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.5. Europe
8.5.1. Europe Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Regulatory Framework
8.5.2.3. Reimbursement Framework
8.5.2.4. UK Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Regulatory Framework
8.5.3.3. Reimbursement Framework
8.5.3.4. Germany Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. Regulatory Framework
8.5.4.3. Reimbursement Framework
8.5.4.4. France Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Regulatory Framework
8.5.5.3. Reimbursement Framework
8.5.5.4. Italy Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Regulatory Framework
8.5.6.3. Reimbursement Framework
8.5.6.4. Spain Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.5.7. Denmark
8.5.7.1. Key Country Dynamics
8.5.7.2. Regulatory Framework
8.5.7.3. Reimbursement Framework
8.5.7.4. Denmark Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.5.8. Sweden
8.5.8.1. Key Country Dynamics
8.5.8.2. Regulatory Framework
8.5.8.3. Reimbursement Framework
8.5.8.4. Sweden Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Regulatory Framework
8.5.9.3. Reimbursement Framework
8.5.9.4. Norway Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.6. Asia Pacific
8.6.1. Asia Pacific Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Regulatory Framework
8.6.2.3. Reimbursement Framework
8.6.2.4. Japan Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Regulatory Framework
8.6.3.3. Reimbursement Framework
8.6.3.4. China Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Regulatory Framework
8.6.4.3. Reimbursement Framework
8.6.4.4. India Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.6.5. Australia
8.6.5.1. Key Country Dynamics
8.6.5.2. Regulatory Framework
8.6.5.3. Reimbursement Framework
8.6.5.4. Australia Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. Regulatory Framework
8.6.6.3. Reimbursement Framework
8.6.6.4. South Korea Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Regulatory Framework
8.6.7.3. Reimbursement Framework
8.6.7.4. Thailand Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.7. Latin America
8.7.1. Latin America Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Regulatory Framework
8.7.2.3. Reimbursement Framework
8.7.2.4. Brazil Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Regulatory Framework
8.7.3.3. Reimbursement Framework
8.7.3.4. Argentina Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.8. Middle East and Africa
8.8.1. Middle East and Africa Parenteral Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Regulatory Framework
8.8.2.3. Reimbursement Framework
8.8.2.4. South Africa Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Regulatory Framework
8.8.3.3. Reimbursement Framework
8.8.3.4. Saudi Arabia Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Regulatory Framework
8.8.4.3. Reimbursement Framework
8.8.4.4. UAE Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Regulatory Framework
8.8.5.3. Reimbursement Framework
8.8.5.4. Kuwait Parenteral Analgesics Market Estimates and Forecasts, 2021-2033 (USD Million/Billion)
Chapter 9. Competitive Landscape
9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
9.5.1. Pfizer Inc.
9.5.1.1. Overview
9.5.1.2. Financial Performance
9.5.1.3. Product Benchmarking
9.5.1.4. Strategic Initiatives
9.5.2. Fresenius Kabi AG
9.5.2.1. Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic Initiatives
9.5.3. Mallinckrodt Pharmaceuticals
9.5.3.1. Overview
9.5.3.2. Financial Performance
9.5.3.3. Product Benchmarking
9.5.3.4. Strategic Initiatives
9.5.4. Hikma Pharmaceuticals PLC
9.5.4.1. Overview
9.5.4.2. Financial Performance
9.5.4.3. Product Benchmarking
9.5.4.4. Strategic Initiatives
9.5.5. Baxter International Inc.
9.5.5.1. Overview
9.5.5.2. Financial Performance
9.5.5.3. Product Benchmarking
9.5.5.4. Strategic Initiatives
9.5.6. Viatris Inc.
9.5.6.1. Overview
9.5.6.2. Financial Performance
9.5.6.3. Product Benchmarking
9.5.6.4. Strategic Initiatives
9.5.7. Teva Pharmaceutical Industries Ltd.
9.5.7.1. Overview
9.5.7.2. Financial Performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic Initiatives
9.5.8. Sun Pharmaceutical Industries Ltd.
9.5.8.1. Overview
9.5.8.2. Financial Performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic Initiatives
9.5.9. Cipla Limited
9.5.9.1. Overview
9.5.9.2. Financial Performance
9.5.9.3. Product Benchmarking
9.5.9.4. Strategic Initiatives
9.5.10. Dr. Reddy's Laboratories Ltd.
9.5.10.1. Overview
9.5.10.2. Financial Performance
9.5.10.3. Product Benchmarking
9.5.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global parenteral analgesics market, region, 2021-2033 (USD Million/Billion)
Table 4 Global parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 5 Global parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 6 Global parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 7 Global parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 8 North America parenteral analgesics market, country, 2021-2033 (USD Million/Billion)
Table 9 North America parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 10 North America parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 11 North America parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 12 North America parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 13 U.S. parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 14 U.S. parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 15 U.S. parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 16 U.S. parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 17 Canada parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 18 Canada parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 19 Canada parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 20 Canada parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 21 Mexico parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 22 Mexico parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 23 Mexico parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 24 Mexico parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 25 Europe parenteral analgesics market, country, 2021-2033 (USD Million/Billion)
Table 26 Europe parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 27 Europe parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 28 Europe parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 29 Europe parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 30 UK parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 31 UK parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 32 UK parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 33 UK parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 34 Germany parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 35 Germany parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 36 Germany parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 37 Germany parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 38 France parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 39 France parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 40 France parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 41 France parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 42 Italy parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 43 Italy parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 44 Italy parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 45 Italy parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 46 Spain parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 47 Spain parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 48 Spain parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 49 Spain parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 50 Norway parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 51 Norway parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 52 Norway parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 53 Norway parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 54 Denmark parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 55 Denmark parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 56 Denmark parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 57 Denmark parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 58 Sweden parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 59 Sweden parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 60 Sweden parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 61 Sweden parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 62 Asia Pacific parenteral analgesics market, country, 2021-2033 (USD Million/Billion)
Table 63 Asia Pacific parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 64 Asia Pacific parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 65 Asia Pacific parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 66 Asia Pacific parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 67 Japan parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 68 Japan parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 69 Japan parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 70 Japan parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 71 China parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 72 China parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 73 China parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 74 China parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 75 India parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 76 India parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 77 India parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 78 India parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 79 Australia parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 80 Australia parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 81 Australia parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 82 Australia parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 83 South Korea parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 84 South Korea parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 85 South Korea parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 86 South Korea parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 87 Thailand parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 88 Thailand parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 89 Thailand parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 90 Thailand parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 91 Latin America parenteral analgesics market, country, 2021-2033 (USD Million/Billion)
Table 92 Latin America parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 93 Latin America parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 94 Latin America parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 95 Latin America parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 96 Brazil parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 97 Brazil parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 98 Brazil parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 99 Brazil parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 100 Argentina parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 101 Argentina parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 102 Argentina parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 103 Argentina parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 104 Middle East & Africa parenteral analgesics market, country, 2021-2033 (USD Million/Billion)
Table 105 Middle East & Africa parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 106 Middle East & Africa parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 107 Middle East & Africa parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 108 Middle East & Africa parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 109 South Africa parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 110 South Africa parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 111 South Africa parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 112 South Africa parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 113 Saudi Arabia parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 114 Saudi Arabia parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 115 Saudi Arabia parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 116 Saudi Arabia parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 117 UAE parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 118 UAE parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 119 UAE parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 120 UAE parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
Table 121 Kuwait parenteral analgesics market, drug class, 2021-2033 (USD Million/Billion)
Table 122 Kuwait parenteral analgesics market, route of administration, 2021-2033 (USD Million/Billion)
Table 123 Kuwait parenteral analgesics market, application, 2021-2033 (USD Million/Billion)
Table 124 Kuwait parenteral analgesics market, end user, 2021-2033 (USD Million/Billion)
List of Figures
Figure 1 Parenteral analgesics market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Competitive landscape
Figure 10 Parenteral analgesics market dynamics
Figure 11 Parenteral analgesics market: Porter’s five forces analysis
Figure 12 Parenteral analgesics market: PESTLE analysis
Figure 13 Opioid analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 14 Non-opioid analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 15 Others market, 2021 - 2033 (USD Million/Billion)
Figure 16 Route of Administration market, 2021 - 2033 (USD Million/Billion)
Figure 17 Intravenous (IV) market, 2021 - 2033 (USD Million/Billion)
Figure 18 Intramuscular (IM) market, 2021 - 2033 (USD Million/Billion)
Figure 19 Subcutaneous (SC) market, 2021 - 2033 (USD Million/Billion)
Figure 20 Others market, 2021 - 2033 (USD Million/Billion)
Figure 21 Application market, 2021 - 2033 (USD Million/Billion)
Figure 22 Acute pain market, 2021 - 2033 (USD Million/Billion)
Figure 23 Chronic pain market, 2021 - 2033 (USD Million/Billion)
Figure 24 End user market, 2021 - 2033 (USD Million/Billion)
Figure 25 Hospitals market, 2021 - 2033 (USD Million/Billion)
Figure 26 Ambulatory surgical centers market, 2021 - 2033 (USD Million/Billion)
Figure 27 Specialty clinics market, 2021 - 2033 (USD Million/Billion)
Figure 28 Others market, 2021 - 2033 (USD Million/Billion)
Figure 29 Parenteral analgesics market revenue, region
Figure 30 Regional marketplace: Key takeaways
Figure 31 North America parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 32 U.S. country dynamics
Figure 33 U.S. parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 34 Canada country dynamics
Figure 35 Canada parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 36 Mexico country dynamics
Figure 37 Mexico parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 38 Europe parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 39 UK country dynamics
Figure 40 UK parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 41 Germany country dynamics
Figure 42 Germany parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 43 France country dynamics
Figure 44 France parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 45 Italy country dynamics
Figure 46 Italy parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 47 Spain country dynamics
Figure 48 Spain parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 49 Norway country dynamics
Figure 50 Norway parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 51 Sweden country dynamics
Figure 52 Sweden parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 53 Denmark country dynamics
Figure 54 Denmark parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 55 Asia Pacific parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 56 Japan country dynamics
Figure 57 Japan parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 58 China country dynamics
Figure 59 China parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 60 India country dynamics
Figure 61 India parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 62 Australia country dynamics
Figure 63 Australia parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 64 South Korea country dynamics
Figure 65 South Korea parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 66 Thailand country dynamics
Figure 67 Thailand parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 68 Latin America parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 69 Brazil country dynamics
Figure 70 Brazil parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 71 Argentina country dynamics
Figure 72 Argentina parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 73 MEA parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 74 South Africa country dynamics
Figure 75 South Africa parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 76 Saudi Arabia country dynamics
Figure 77 Saudi Arabia parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 78 UAE country dynamics
Figure 79 UAE parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 80 Kuwait country dynamics
Figure 81 Kuwait parenteral analgesics market, 2021 - 2033 (USD Million/Billion)
Figure 82 Company categorization
Figure 83 Company market position analysis
Figure 84 Strategic framework

Companies Mentioned

  • Pfizer Inc.
  • Fresenius Kabi AG
  • Mallinckrodt Pharmaceuticals
  • Hikma Pharmaceuticals PLC
  • Baxter International Inc.
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.